Northalifoline



Compound IDCDAMM01993
Common nameNorthalifoline
IUPAC name7-hydroxy-6-methoxy-3,4-dihydro-2H-isoquinolin-1-one
Molecular formulaC10H11NO3

Experimental data

Retention time10.77
Adduct[M+H]+
Actual mz194.078
Theoretical mz194.081
Error14.82
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.2246

Identifiers and class information

Inchi keyHSLDNQNDHKZKNZ-UHFFFAOYSA-N
SmilesO=C1NCCC2=CC(OC)=C(O)C=C12
SuperclassOrganoheterocyclic compounds
ClassIsoquinolines and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)2
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)193.202
Computed dipole moment(dipole)5.362
Total solvent accessible surface area (SASA)401.628
Hydrophobic component of SASA (FOSA)198.032
Hydrophilic component of SASA (FISA)134.908
Pie component of the SASA (PISA)68.688
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)646.925
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)4
Free energy of solvation of dipole (dip^2/V)0.0444404
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0140848
Globularity descriptor (glob)0.900693
Predicted polarizability in cubic angstroms (QPpolrz)19.108
Predicted hexadecane/gas partition coefficient (QPlogPC16)6.161
Predicted octanol/gas partition coefficient (QPlogPoct)11.47
Predicted water/gas partition coefficient (QPlogPw)8.499
Predicted octanol/water partition coefficient (QPlogPo/w)0.739
Predicted aqueous solubility (QPlogS)-2.013
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.097
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.466
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)520.67
Predicted brain/blood partition coefficient (QPlogBB)-0.666
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)244.336
Predicted skin permeability, log Kp (QPlogKp)-3.572
PM3 calculated ionization potential (IP(ev))8.925
PM3 calculated electron affinity (EA(eV))0.231
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)-0.418
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)79.896
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)72.294
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43166CA7Carbonic anhydrase VIIT37541SEA
P41595HTR2BSerotonin 2b (5-HT2b) receptorT31204SEA
P49137MAPKAPK2MAP kinase-activated protein kinase 2T21307SEA
P21728DRD1Dopamine D1 receptorT22118SEA
O14757CHEK1Serine/threonine-protein kinase Chk1T62449SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
O00311CDC7CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase)T81358SEA
P78368CSNK1G2Casein kinase I gamma 2T82773SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
Q96KB5PBKPDZ-binding kinaseT98642SEA
P51511MMP15Matrix metalloproteinase 15T81658SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
Q9UQM7CAMK2ACaM kinase II alphaT18299SEA
Q96PF2TSSK2Testis-specific serine/threonine-protein kinase 2T04413SEA
O43781DYRK3Dual-specificity tyrosine-phosphorylation regulated kinase 3T97149SEA
Q9UEE5STK17ASerine/threonine-protein kinase 17AT91323SEA
P01100FOSProto-oncogene c-FosT28025SEA
Q96RG2PASKPAS domain-containing serine/threonine-protein kinaseT37371SEA
Q9NXA8SIRT5NAD-dependent deacetylase sirtuin-5T91940SEA
Q9NR20DYRK4Dual-specificity tyrosine-phosphorylation regulated kinase 4T20542SEA
Q8TDC3BRSK1BR serine/threonine kinase 1T20053SEA
Q9Y6M4CSNK1G3Casein kinase I gamma-3T29728SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T31204DI0040Attention deficit hyperactivity disorder[ICD-11: 6A05]P41595HTR2B
T31204DI0117Depression[ICD-11: 6A70-6A7Z]P41595HTR2B
T31204DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P41595HTR2B
T31204DI0354Psychotic disorder[ICD-11: 6A20-6A25]P41595HTR2B
T21307DI0011Acute laryngitis/tracheitis[ICD-11: CA05]P49137MAPKAPK2
T21307DI0181Hidradenitis suppurativa[ICD-11: ED92]P49137MAPKAPK2
T21307DI0269Monogenic autoinflammatory syndrome[ICD-11: 4A60]P49137MAPKAPK2
T21307DI0334Peritoneal cancer[ICD-11: 2C51]P49137MAPKAPK2
T21307DI0352Psoriatic arthritis[ICD-11: FA21]P49137MAPKAPK2
T21307DI0366Rheumatoid arthritis[ICD-11: FA20]P49137MAPKAPK2
T21307DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P49137MAPKAPK2
T22118DI0003Abortion[ICD-11: JA00]P21728DRD1
T22118DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]P21728DRD1
T22118DI0190Hypertension[ICD-11: BA00-BA04]P21728DRD1
T22118DI0331Parkinsonism[ICD-11: 8A00]P21728DRD1
T62449DI0027Anal cancer[ICD-11: 2C00]O14757CHEK1
T62449DI0172Head and neck cancer[ICD-11: 2D42]O14757CHEK1
T62449DI0183Hodgkin lymphoma[ICD-11: 2B30]O14757CHEK1
T62449DI0238Lung cancer[ICD-11: 2C25]O14757CHEK1
T62449DI0241Lymphoma[ICD-11: 2A80-2A86]O14757CHEK1
T62449DI0321Ovarian cancer[ICD-11: 2C73]O14757CHEK1
T62449DI0326Pancreatic cancer[ICD-11: 2C10]O14757CHEK1
T62449DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]O14757CHEK1
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T81358DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]O00311CDC7
T81358DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]O00311CDC7
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T98642DI0291Nasopharyngeal cancer[ICD-11: 2B6B]Q96KB5PBK
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2
T18299DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UQM7CAMK2A

Copyright © 2025